Virtual Conference 2024
- In collaboration with Osteo Science Foundation -
Join Us for a Cutting-Edge Virtual Conference on Advanced OMF Surgery Techniques
Tuesday, December 10, 2024 | 8-10am CST
IAOMS - in collaboration with Osteo Science Foundation - invites you to attend a groundbreaking Virtual Conference focused on advanced oral and maxillofacial surgery techniques. This unique event brings together leading experts in the field to discuss complex case management in the aesthetic region and innovations in blood products for oral and maxillofacial regeneration.
Why Attend:
- Learn from global experts on oral and maxillofacial surgery.
- Get practical tips on managing soft and hard tissue in challenging cases.
- Discover how to improve patient outcomes using the latest regenerative techniques.
Key Benefits:
- Expand your knowledge with hands-on, real-world applications.
- Engage directly with the speakers during an interactive Q&A session.
- Earn [#] CE credits for your participation.
You will need your IAOMS account information to register. If you do not have an IAOMS account, you can create one for free. If you need assistance retrieving your IAOMS account information, please utilize the password reset link.
Session 1 | 8-8:45am
Blood Products for Oral and Maxillofacial Regeneration
Presented by: Tara Aghaloo, DDS, MD, PhD
Bone healing and regeneration, especially in the oral and maxillofacial region, poses significant challenges for the practicing clinician. Although autogenous bone is the gold standard for regenerative procedures, major complications, limited availability, and technical sensitivity cause clinicians to search for alternative strategies and techniques to improve outcomes.
With the popularity of tissue engineering and regenerative medicine, stem cells, growth factors, and scaffolds are now being discussed between surgeons and patients. However, regulatory limitations, high costs, and complex medical histories often prevent surgeons from offering the latest regenerative techniques to all patients. In this case, how do oral and maxillofacial surgeons improve hard and soft tissue grafting outcomes?
The use of blood products, specifically platelet concentrates, have become extremely popular for regenerative procedures. Whether used to improve vascularity, aid in soft tissue healing, or congeal particulate bone graft material together, autologous blood products are in a surgeon’s daily armamentarium.
This presentation will discuss the use of autologous blood products in oral and maxillofacial regeneration, including indications, techniques, complications, and outcomes.
Learning Objectives:
-
Discuss the use of autologous blood products in oral and maxillofacial regeneration.
-
Review the benefits and pitfalls of using autologous blood products.
-
Explore the science behind these innovative products.
About the Presenter:
Dr. Tara Aghaloo is a Professor in Oral and Maxillofacial Surgery at the UCLA School of Dentistry. She completed her dental training at the University of Missouri-Kansas City, and Oral and Maxillofacial Surgery residency, MD, and PhD in Oral Biology at UCLA. She is a diplomate of the American Board of Oral and Maxillofacial Surgery, and is a board examiner for the specialty. She has a very active clinical practice focusing on bone and soft tissue regeneration, dental implant surgery, and osteonecrosis of the jaws. She is also active in professional organizations where she is the Associate Editor for the Journal of Oral and Maxillofacial Surgery, Past-President of the Academy of Osseointegration (AO), and a member of several American Association of Oral and Maxillofacial Surgeons (AAOMS) committees.
Session 2 | 8:45-9:30am
Management of Complex Cases in the Aesthetic Region
Presented by: Jorge Caubet Biayna, GJJ, MD, PhD, FEBOMS
It is well known that rehabilitating complex cases in the aesthetic region with implants is challenging. Proper analysis of the soft tissue, hard tissue, the sequence between grafting and implantation, as well as patient selection, are all crucial factors.
The objectives of this presentation are threefold: first, the proper management of soft tissue; second, when and how to perform bone grafting; and third, the correct sequence for implant placement.
The clinical management of the aesthetic sector involves two crucial factors: first, achieving a predictable outcome, and second, ensuring that any intervention is based on scientific evidence.
The maxillofacial surgeon works in collaboration with the prosthodontist, and the treatment plan should be developed jointly. Analyzing bone mass alone is not sufficient; it’s also necessary to consider the profile of the soft tissue, the presence of adjacent teeth or implants, lip position, smile line, and the patient’s facial characteristics. Aesthetic results demand symmetry, appropriate gingival margins, and dental exposure, which should be assessed preoperatively.
In this presentation, we will begin by reviewing the key factors in managing the aesthe?c sector, focusing on those described between 2000 and 2010. We will review the main surgical techniques to address bone defects: cortical graft, particulate grafts, and guided bone regeneration. We will also examine the indications for connective tissue grafting prior to bone graft placement. Additionally, we will cover the indications for regeneration and analyze cases of complications and how they have been resolved.
Learning Objectives:
- Review the management of soft tissue in the aesthetic region.
- Explore when and how to perform bone grafting.
- Understand the correct sequence for implant placement.
|
About the Jorge Caubet Biayna completed his medical studies at the Autonoma University of Barcelona. After finishing his medical degree, he passed the MIR exam to pursue specialized training in Oral and Maxillofacial Surgery. He obtained his PhD at the Autonoma University of Barcelona, graduating with the distinction of "summa cum laude." Dr. Caubet specialized in clinical practice focusing on implantology and bone regeneration in Palma de Mallorca, where he works exclusively as an Oral andMaxillofacial Surgeon, dedicated to implantology and bone regeneration. He is also a Visiting professor in the Master's program in Implants and Periodontics at the Faculty of Dentistry at the University of Seville and Fellow of the European Board on Oral and Maxillofacial Surgery. Wrap Up | 9:30-10am Interactive Discussion and Q&AEngage with our experts and ask your most pressing questions during this interactive session moderated by G. E. Ghali, DDS, MD, FACS, FRCS (Ed), providing valuable real-time insights.
|
Presenter:
Moderator:
About Osteo Science Foundation:
Osteo Science Foundation’s mission is to advance hard and soft tissue regeneration with a focus on Oral and Craniomaxillofacial Surgery. The Foundation was established by Peter Geistlich in 2013 and is funded by Geistlich Pharma, a global leader in regenerative medicine for Oral and Craniomaxillofacial Surgery. Osteo Science Foundation is dedicated to advancing scientific research and education that leads to improved outcomes for patients, and operates as an independent, privately-funded 501(c)(3) non-profit organization. For more information, please visit www.osteoscience.org.
Complimentary registration for this Virtual Conference has been provided by Osteo Science Foundation. IAOMS would like to thank Osteo Science Foundation for their support of this program.